CRISPR biotech targets cancer, autoimmune disease
A new biotech that is using CRISPR gene-editing technology to discover drugs for cancer and autoimmune diseases is opening a lab in Branford after raising...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
A new biotech that is using CRISPR gene-editing technology to discover drugs for cancer and autoimmune diseases is opening a lab in Branford after raising...
ReNetX Bio has been awarded a $3 million SBIR Phase II grant from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke. ReNetX...
New Haven-based Trevi Therapeutics has named three new high-level leaders. “We are pleased to welcome Shashank Rohatagi, Farrell Simon, and Kathy Takaki to our management team...
In fiscal year 2020, researchers from UConn and UConn Health secured nearly $286 million in research and other types of sponsored funding, the most in...
Last August, the Yale Center for Clinical Investigation began participating in a clinical trial for a coronavirus vaccine being developed by the pharmaceutical company Pfizer...
New Haven biotech Arvinas has unveiled five new preclinical programs that aim to treat various types of cancer and a fatal neurological disorder. Arvinas’s drugs...
Yale’s Craig Crews has been awarded the international Heinrich Wieland Prize for his discovery of new methods to target disease-causing proteins, the Boehringer Ingelheim Foundation...
Vanessa Research reports that its subsidiary, HGA Biomed Pharmaceutical Manufacturing Ltd. (HGA), based in Kaposvár, Hungary, was awarded a prestigious Remembrance Medal. HGA was one...
Pfizer Chairman and CEO Albert Bourla writes: As we get closer to an important data readout from our COVID-19 vaccine program, I wanted to speak...
Branford biotech Azitra has doubled its lifetime venture capital fundraising with a $17 million round led by the investment arm of pharma giant Bayer. Azitra...